Physician profile
John Walter Entwistle
NPI 1831132398
$9,467.39
in general payments reported to CMS, 2019-2025
15 companies · $1,472 in 2025
The $1,472 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,354 · 2020: $1,167 · 2021: $1,310 · 2022: $1,400 · 2023: $1,909 · 2024: $856 · 2025: $1,472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,236.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $2,165.15 | 2019-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Abbott Laboratories | $2,016.53 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Edwards Lifesciences Corporation | $2,011.98 | 2019-2025 | Sapien 3 Ultra Resilia |
| Medtronic, INC. | $777.41 | 2021-2025 | Symplicity G3, Corevalve Evolut R |
| Abiomed | $678.97 | 2020-2025 | Impella |
| Baxter Healthcare | $572.56 | 2019-2025 | Preveleak, Floseal, Coseal |
| Medtronic Vascular, INC. | $437.88 | 2019-2020 | |
| Artivion, INC. | $297.11 | 2019-2022 | |
| Boston Scientific Corporation | $149.76 | 2020 | |
| Novartis Pharmaceuticals Corporation | $123.38 | 2023-2025 | |
| Amgen INC. | $100.54 | 2023-2025 | Repatha, Repatha |
| Zimmer Biomet Holdings, INC. | $81.03 | 2021-2025 | |
| Smith+Nephew, INC. | $19.99 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $18.46 | 2023 | Camzyos |
| Depuy Synthes Sales INC. | $16.64 | 2023 | Matrixrib, Zipfix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Entwistle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.